glp-1 and insulin resistance GLP-1R Diabetes GLP-1: Actions on Beta-cell Mass

Semaglutide for the treatment of obesity

When this happens, you may feel dizzy or fatigue

Cell Death Dis 16(1):259 Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at 61st EASD Annual Meeting 2025, Wien [press release] Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST et al (2011) The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial

Rodrguez-Meja UU et al

Early optimism in the use of GLP-1 therapies for Parkinsons disease has been tempered by the recent failure of a Phase III exenatide trial which did not show any benefits of slowing Parkinsons progression 10

This step is crucial for maintaining progress in your weight loss journey